InvestSMART

Mayne Pharma Group Limited (ASX: MYX) - Announcements

Current share price for MYX : $2.830 0.02 (0.71%)+

ASX company news and announcements for Mayne Pharma Group Limited (MYX) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Mayne Pharma Group Limited (MYX) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Mayne Pharma Group Limited (MYX), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Mayne Pharma Group Limited (MYX)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$232 Results of Meeting 26 Nov 2015 12:39PM $1.265 $2.830 risen by 123.72%
$232 2015 AGM CEO's Speech 26 Nov 2015 8:28AM $1.235 $2.830 risen by 129.15%
$232 2015 AGM Chairman's Speech 26 Nov 2015 8:28AM $1.235 $2.830 risen by 129.15%
$232 Appendix 3B 12 Nov 2015 8:32AM $1.110 $2.830 risen by 154.95%
$232 Notice of Annual General Meeting/Proxy Form 23 Oct 2015 10:40AM $1.040 $2.830 risen by 172.12%
$232 Appendix 4G 9 Oct 2015 1:05PM $1.040 $2.830 risen by 172.12%
$232 Appendix 3B and lapse of employee options 22 Sep 2015 8:29AM $1.040 $2.830 risen by 172.12%
$232 Change of Director's Interest Notices 7 Sep 2015 10:15AM $1.035 $2.830 risen by 173.43%
$232 2015 Corporate Governance Statement 28 Aug 2015 8:34AM $1.090 $2.830 risen by 159.63%
$232 2015 Full Year Results Investor Presentation 28 Aug 2015 8:34AM $1.090 $2.830 risen by 159.63%
$232 2015 Full Year Results Media Release 28 Aug 2015 8:34AM $1.090 $2.830 risen by 159.63%
$232 2015 Appendix 4E & Annual Report 28 Aug 2015 8:27AM $1.090 $2.830 risen by 159.63%
$232 Mayne announces strategic investment in US facilities 28 Aug 2015 8:27AM $1.090 $2.830 risen by 159.63%
$232 Appendix 3B 26 Aug 2015 1:59PM $1.055 $2.830 risen by 168.25%
$232 Mayne Pharma launches Doryx 50mg Tablet 10 Aug 2015 9:13AM $1.155 $2.830 risen by 145.02%
$232 Ceasing to be a substantial holder 7 Aug 2015 5:35PM $1.155 $2.830 risen by 145.02%
$232 Appendix 3B 5 Aug 2015 11:55AM $1.220 $2.830 risen by 131.97%
$232 Mayne Pharma appoints new senior management 5 Aug 2015 8:45AM $1.210 $2.830 risen by 133.88%
$232 Mayne Pharma recipient of A$4m Government Grant 4 Aug 2015 2:26PM $1.210 $2.830 risen by 133.88%
$232 Appendix 3B 4 Aug 2015 9:54AM $1.200 $2.830 risen by 135.83%
$232 Appendix 3B and lapse of employee options 13 Jul 2015 2:58PM $1.130 $2.830 risen by 150.44%
$232 Mayne Pharma successfully completes US$125m debt financing 25 Jun 2015 9:21AM $1.055 $2.830 risen by 168.25%
$232 Appendix 3B 23 Jun 2015 8:51AM $1.055 $2.830 risen by 168.25%
$232 Change of registered office address 22 Jun 2015 10:36AM $1.060 $2.830 risen by 166.98%
$232 Appendix 3B 28 May 2015 12:33PM $1.120 $2.830 risen by 152.68%

826 - 850 of 901 results

Page 34 of 37

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.